Kevin Doody

Insider

First SEC filing: Sept. 26, 2019 · Latest: Sept. 26, 2019

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Dec. 31, 2020	IVF	A	10,947	—	—	10,947 Direct	—	Acquired	(price as of 2026-08-21)
Dec. 31, 2020	IVF	A	8,184	—	—	169,821 Direct	+5.06%	Acquired	(price as of 2026-08-21)
Feb. 5, 2020	IVF	A	99,112	—	—	99,112 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 5, 2020	IVF	A	99,112	—	—	99,112 Direct	—	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Dec. 31, 2020	IVF	Stock Option	Common Stock (10,947)	$3.06	Dec. 31, 2030	10,947	Acquired
Feb. 5, 2020	IVF	Restricted Stock Units	Common Stock (99,112)	$0.00	Feb. 5, 2030	99,112	Acquired
Feb. 5, 2020	IVF	Stock Option	Common Stock (99,112)	$0.25	Feb. 5, 2030	99,112	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Sept. 26, 2019	IVF	Common Stock	5,073,197	Direct